Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Hello. Good evening and good morning. I'm James Gordon, JPMorgan Pharma and Biotech analyst and today, at the JPMorgan conference, have the pleasure of introducing the Takeda presentation and hosting the Q&A. So we have Takeda President and CEO, Christophe Weber, joining us for this 20-minute presentation. And then we can have other members of Takeda management joining us for the Q&A afterwards. And I'm looking forward to the presentation a lot, so over to you, Christophe.
Thank you, James. Hello, everyone. Thank you all for joining us today. While many of us, we are looking forward to gathering in San Francisco for the annual conference and yet COVID-19 continues to put the world on notice as we still have a long road ahead of us. The latest development in this devastating pandemic continued to remind us of the importance of our work for patients and society. But I'm
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |